Gastroenterology society bestows ‘shark tank’ honor to Montreal firm
The Society of American Gastrointestinal and Endoscopic Surgeons has selected Montreal-based FemTherapeutics the winner of its 2025 “shark tank”-style competition at its annual meeting in Long Beach, Calif.
The competition is designed to support clinicians focused on commercializing their innovations through investment capital, according to a March 27 press release sent to Becker’s.
As the winner, FemTherapeutics earns a $30,000 investment from SAGES. Other runner-ups for 2025 include Suture Shield, Qaelon and Evolving Education.
FemTherapeutics aims to provide solutions for common pelvic health conditions, and its flagship product is a personalized intravaginal prosthetic designed to manage pelvic organ prolapse. The company hopes to use the money to expand into incontinence, pelvic pain and maternal health.
The post Society of American Gastrointestinal and Endoscopic Surgeons awards ‘shark tank’ winner appeared first on Becker’s ASC.
